Clinical Trial Update: Randomized, Placebo-controlled Study Comparing Efficacy of Fluticasone/Salmeterol Combination to Advair in Asthmatics [Phase 3]

View source ↗

Summary

A Phase 3 randomized, placebo-controlled trial comparing a fluticasone/salmeterol combination to Advair in asthmatics was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Advair (fluticasone propionate/salmeterol)
• Fluticasone/Salmeterol (fluticasone/salmeterol)

Snippet

Sponsor: Actavis Inc. | Conditions: Asthma | Phase 3 | Status: WITHDRAWN